Ligand validation:7PT1

3KK: S-{(3R,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} 2-hydroxy-2-methylpropanethioate

3KK is a Ligand Of Interest in 7PT1 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7PT1_3KK_B_702	98%	54%	0.063	0.983	0.96	0.84	2	-	2	0	100%	1
7PT1_3KK_A_702	96%	50%	0.069	0.978	0.9	1.03	2	3	1	0	100%	1
7PT3_3KK_B_702	99%	57%	0.064	0.991	0.76	0.87	2	3	0	0	100%	1
7PT2_3KK_B_702	95%	50%	0.079	0.984	1.12	0.83	6	-	1	0	100%	1
4R3U_3KK_A_802	77%	25%	0.123	0.962	1.55	1.49	6	5	3	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.